10 Important GLP-1 Side Effects You Should Be Aware Of

GLP-1 side effects commonly include nausea, vomiting, diarrhea, constipation, abdominal pain, acid reflux, headaches, fatigue, dizziness, and injection site reactions. These symptoms can occur with medications such as Ozempic, Wegovy, Mounjaro, and Zepbound, particularly when starting treatment or increasing the dosage.

Most GLP-1 side effects are mild to moderate and improve as the body adjusts, although persistent symptoms can sometimes cause dehydration, nutritional problems, or treatment interruptions. Understanding these potential reactions helps patients recognize symptoms and determine when medical attention is necessary.

DFWPMA offers in-person GLP-1 prescription evaluations in Texas and can prescribe GLP-1 medications at a DFWPMA location across Texas to eligible patients when medically appropriate, subject to medication availability.

Our primary care providers and endocrinologists also offer ongoing care to monitor potential side effects, address health concerns, and support patients throughout GLP-1 treatment. DFWPMA does not currently offer online GLP-1 prescriptions, an in-person evaluation is required.

Book an appointment online or call (903) 957-0082 to contact our scheduling team.

Get Prescriptions for GLP-1 Medications at a DFWPMA Location Near You!

📍 GLP-1 Prescription Providers in Fort Worth, TX

1220 W Presidio St, Fort Worth, TX 76102

Book an Appointment at Our Fort Worth Location →
📍 GLP-1 Prescription Providers in Frisco, TX

7589 Preston Rd., Suite 900, Frisco, TX 75034

Book an Appointment at Our Frisco Location →
📍 GLP-1 Prescription Providers in Sherman, TX

425 N Highland Ave., Suite 260, Sherman, TX 75092

Book an Appointment at Our Sherman Location →
📞 Call DFWPMA to Schedule

Speak with our scheduling team about GLP-1 prescription evaluations, provider availability, and appointments.

Call Us → (903) 957-0082

We accept many major insurance plans. Not sure if your plan is accepted?

Call (903) 957-0082 and our team can help verify coverage.

Side Effect #1: Nausea

What Is Nausea?

Nausea is an uncomfortable sensation in the stomach that creates the urge to vomit. It is one of the most frequently reported GLP-1 side effects, particularly during the first several weeks of treatment or following a dosage increase. GLP-1 medications slow gastric emptying and influence appetite-regulating pathways, which can contribute to nausea, especially after eating large meals.

Potential Consequences of Experiencing This Side Effect

GLP-1-related nausea is usually temporary, but persistent symptoms can interfere with eating, drinking, and maintaining adequate nutrition. Patients who experience significant nausea may struggle to tolerate meals or continue their prescribed treatment. Potential consequences include:

  • Reduced Food Intake: Persistent nausea may make eating uncomfortable and lead to inadequate calorie consumption.
  • Loss of Appetite: Patients may develop an aversion to food that extends beyond the medication’s intended appetite-suppressing effects.
  • Dehydration: Nausea may discourage adequate fluid intake, particularly when accompanied by vomiting.
  • Nutritional Deficiencies: Prolonged difficulty eating balanced meals can contribute to insufficient protein, vitamin, or mineral intake.
  • Treatment Discontinuation: Severe or persistent nausea may lead patients to stop GLP-1 therapy before achieving their treatment goals.

How to Treat This GLP-1 Side Effect

GLP-1-related nausea is typically managed through dietary adjustments, smaller meals, and changes to the medication regimen when clinically appropriate. Healthcare providers may recommend avoiding foods that worsen nausea, monitoring hydration, or temporarily delaying dosage increases. Persistent symptoms may require further evaluation to determine whether additional treatment or medication adjustments are necessary.

Side Effect #2: Vomiting

What Is Vomiting?

Vomiting is the forceful expulsion of stomach contents through the mouth. It is a recognized GLP-1 side effect that may occur when delayed gastric emptying and medication-related nausea interfere with normal digestive function. Vomiting is more likely during treatment initiation or dosage escalation, although its frequency and severity vary between patients and medications.

Potential Consequences of Experiencing This Side Effect

Repeated vomiting can become medically concerning because it causes fluid loss, disrupts electrolyte balance, and interferes with normal nutrition. Patients who cannot keep liquids down may require prompt medical evaluation. Potential consequences include:

  • Severe Dehydration: Repeated vomiting can cause substantial fluid loss and reduce circulating blood volume.
  • Electrolyte Imbalances: Vomiting may disrupt potassium, sodium, and chloride levels, potentially affecting normal muscle and heart function.
  • Acute Kidney Injury: Significant dehydration can reduce blood flow to the kidneys and impair their ability to filter waste.
  • Esophageal Irritation: Repeated exposure to stomach acid can irritate the esophagus and cause burning or discomfort.
  • Inadequate Nutrition: Frequent vomiting can prevent patients from retaining sufficient calories, protein, and essential nutrients.

How to Treat This GLP-1 Side Effect

Vomiting associated with GLP-1 medications is generally managed by addressing fluid loss, assessing symptom severity, and reviewing medication tolerance. Healthcare providers may recommend dietary modifications, hydration support, or adjustments to the treatment regimen. Persistent vomiting may require laboratory testing, additional medical evaluation, or treatment for dehydration and electrolyte imbalances.

Side Effect #3: Diarrhea

What Is Diarrhea?

Diarrhea is the passage of loose or watery stools more frequently than normal. It is a common gastrointestinal side effect of GLP-1 medications, including semaglutide and tirzepatide. Changes in digestive motility and gastrointestinal function may contribute to diarrhea, particularly during the early stages of treatment or after dosage increases.

Potential Consequences of Experiencing This Side Effect

Occasional diarrhea may resolve without complications, but frequent or prolonged episodes can cause substantial fluid and electrolyte losses. Patients experiencing persistent diarrhea during GLP-1 treatment should be evaluated for dehydration and other possible causes. Potential consequences include:

  • Dehydration: Frequent watery stools can cause excessive fluid loss, particularly when patients cannot replace fluids adequately.
  • Electrolyte Depletion: Persistent diarrhea may reduce potassium and other electrolytes necessary for normal bodily functions.
  • Abdominal Cramping: Increased intestinal activity can produce painful contractions and digestive discomfort.
  • Skin Irritation: Frequent bowel movements may irritate the skin surrounding the anus and cause soreness.
  • Kidney Complications: Severe fluid depletion may contribute to acute kidney injury, especially in patients with existing kidney disease.

How to Treat This GLP-1 Side Effect

GLP-1-related diarrhea is typically managed through hydration, dietary modifications, and monitoring for signs of fluid or electrolyte loss. Healthcare providers may evaluate whether symptoms are associated with medication dosage, dietary factors, or another gastrointestinal condition. Persistent or severe diarrhea may require additional testing, supportive treatment, or adjustments to the prescribed medication regimen.

Contraindication #5: Pancreatitis

What Is Pancreatitis?

Pancreatitis is inflammation of the pancreas, an organ responsible for producing digestive enzymes and hormones that regulate blood sugar. Acute pancreatitis has been reported in patients taking GLP-1 medications. A history of pancreatitis is not a universal absolute contraindication, but it requires careful medical evaluation. If acute pancreatitis is suspected during treatment, the medication should be stopped and the patient evaluated promptly.

Potential Consequences of Taking GLP-1 Medications with This Condition

Acute pancreatitis can become a medical emergency, particularly when inflammation causes tissue damage or affects other organs. Although a direct causal relationship between GLP-1 medications and pancreatitis has not been conclusively established, ignoring symptoms during treatment can delay essential care. Potential consequences include:

  • Severe Abdominal Pain: Pancreatic inflammation can cause persistent upper abdominal pain that may radiate to the back.
  • Persistent Vomiting: Pancreatitis may produce severe nausea and vomiting that interfere with hydration and nutrition.
  • Pancreatic Tissue Damage: Severe inflammation can cause pancreatic necrosis, in which portions of pancreatic tissue die.
  • Organ Failure: Severe acute pancreatitis can affect kidney, lung, and cardiovascular function.
  • Life-Threatening Complications: Severe pancreatitis may cause systemic inflammation, infection, or death.

Contraindication #6: Severe Gastroparesis

What Is Gastroparesis?

Gastroparesis is a digestive disorder in which the stomach empties food more slowly than normal without a mechanical obstruction. GLP-1 medications can further delay gastric emptying, potentially worsening symptoms. Severe gastroparesis is an important prescribing precaution, and several GLP-1 medications are not recommended for patients with this condition.

Potential Consequences of Taking GLP-1 Medications with This Condition

Patients with severe gastroparesis may experience worsening digestive symptoms when taking medications that slow gastric emptying. Persistent symptoms can interfere with nutrition, hydration, and medication absorption. Potential consequences include:

  • Persistent Nausea: Delayed stomach emptying can cause ongoing nausea, especially after meals.
  • Recurrent Vomiting: Food remaining in the stomach for prolonged periods may contribute to repeated vomiting.
  • Severe Abdominal Discomfort: Patients may experience bloating, upper abdominal pain, and uncomfortable fullness.
  • Malnutrition: Difficulty tolerating adequate meals can lead to insufficient calorie and nutrient intake.
  • Dehydration and Electrolyte Imbalances: Repeated vomiting and inadequate fluid intake may disrupt normal hydration and electrolyte levels.

Contraindication #7: Gallbladder Disease

What Is Gallbladder Disease?

Gallbladder disease refers to conditions affecting the gallbladder, including gallstones (cholelithiasis) and gallbladder inflammation (cholecystitis). GLP-1 treatment and substantial weight loss may be associated with an increased risk of gallbladder complications. Existing gallbladder disease is not generally an absolute contraindication, but symptoms or a relevant medical history warrant evaluation.

Potential Consequences of Taking GLP-1 Medications with This Condition

Unrecognized gallbladder disease can progress from intermittent abdominal discomfort to serious inflammation or obstruction. Patients taking GLP-1 medications who develop persistent upper abdominal pain, particularly with fever or jaundice, require medical evaluation. Potential consequences include:

  • Gallstone Attacks: Gallstones may obstruct bile flow and cause sudden, intense upper abdominal pain.
  • Acute Cholecystitis: Gallbladder inflammation can cause persistent pain, fever, and tenderness.
  • Bile Duct Obstruction: Gallstones entering the bile ducts can interfere with bile drainage and cause jaundice.
  • Gallstone Pancreatitis: A gallstone blocking the pancreatic drainage pathway may trigger acute pancreatitis.
  • Gallbladder Infection: Untreated obstruction and inflammation may lead to serious infection requiring hospitalization or surgery.

Contraindication #8: Kidney Problems and Severe Dehydration

What Are Kidney Problems and Severe Dehydration?

Kidney problems involve impaired kidney function, while severe dehydration occurs when the body loses more fluid than it can replace. GLP-1 medications may cause nausea, vomiting, or diarrhea that leads to dehydration and acute kidney injury. Chronic kidney disease is not automatically a contraindication to every GLP-1 medication, but patients with impaired kidney function or significant fluid loss may require closer monitoring.

Potential Consequences of Taking GLP-1 Medications with This Condition

Persistent dehydration can reduce blood flow to the kidneys and contribute to acute kidney injury. Patients with existing kidney disease may be particularly vulnerable to complications from substantial fluid loss. Potential consequences include:

  • Acute Kidney Injury: Reduced kidney blood flow can cause a sudden decline in the kidneys’ ability to filter waste.
  • Electrolyte Imbalances: Fluid losses and impaired kidney function may disrupt sodium, potassium, and other electrolyte levels.
  • Low Blood Pressure: Severe dehydration can reduce circulating blood volume and cause dizziness or fainting.
  • Worsening Kidney Function: Patients with preexisting kidney impairment may experience additional deterioration during dehydration-related illness.
  • Hospitalization: Severe dehydration or acute kidney injury may require intravenous fluids, laboratory monitoring, or inpatient treatment.

Contraindication #9: Hypoglycemia Risk With Other Diabetes Medications

What Is Hypoglycemia?

Hypoglycemia is an abnormally low blood glucose level, generally defined as below 70 mg/dL in people with diabetes. GLP-1 medications have a relatively low risk of causing hypoglycemia when used alone, but combining them with insulin or sulfonylureas can increase that risk. This drug combination is not automatically contraindicated, although medication adjustments and glucose monitoring may be necessary.

Potential Consequences of Taking GLP-1 Medications with This Condition

Severe hypoglycemia can interfere with normal brain function because glucose is an essential energy source for the brain. Patients taking GLP-1 medications alongside insulin or insulin-releasing drugs may require dosage adjustments to prevent dangerous blood sugar reductions. Potential consequences include:

  • Shaking and Sweating: Falling blood sugar can activate the body’s stress response, causing tremors, sweating, and palpitations.
  • Confusion: Inadequate glucose delivery to the brain may impair concentration, judgment, and coordination.
  • Loss of Consciousness: Severe hypoglycemia may cause fainting or an inability to respond normally.
  • Seizures: Extremely low blood glucose can disrupt brain activity and trigger seizures.
  • Hypoglycemic Coma: Prolonged, severe hypoglycemia can cause coma and potentially permanent neurological injury.

Contraindication #10: Diabetic Retinopathy

What Is Diabetic Retinopathy?

Diabetic retinopathy is an eye disease caused by damage to retinal blood vessels associated with diabetes. Rapid improvements in blood glucose levels can sometimes temporarily worsen existing diabetic retinopathy. Patients with a history of diabetic retinopathy may require additional eye monitoring when starting certain GLP-1 medications. Diabetic retinopathy is not generally an absolute contraindication to GLP-1 treatment.

Potential Consequences of Taking GLP-1 Medications with This Condition

Patients with existing diabetic retinopathy may experience worsening retinal disease during periods of rapid blood sugar improvement, making appropriate eye monitoring important. These complications are consequences of diabetic retinopathy itself and are not all established direct effects of GLP-1 medications. Potential consequences include:

  • Blurred Vision: Retinal swelling or changes in blood vessels may reduce visual clarity.
  • Macular Edema: Fluid accumulation in the central retina can impair detailed vision.
  • Retinal Hemorrhage: Damaged retinal blood vessels may leak or bleed into surrounding tissue.
  • Retinal Detachment: Advanced proliferative diabetic retinopathy can cause scar tissue that pulls the retina away from its normal position.
  • Permanent Vision Loss: Advanced or untreated diabetic retinopathy may result in irreversible visual impairment or blindness.

DFWPMA Can Help You Manage GLP-1 Side Effects

At DFW Physicians Medical Associates (DFWPMA), our medical providers offer GLP-1 prescription evaluations in Texas and ongoing medical care for patients using medications such as Ozempic, Wegovy, Mounjaro, and Zepbound. 

Our multidisciplinary team includes providers specializing in family medicine, primary care, urgent care, endocrinology, and internal medicine. Depending on the patient’s needs, these providers can evaluate GLP-1 side effects such as nausea, vomiting, diarrhea, constipation, and fatigue, assess medication tolerance, and coordinate appropriate follow-up care.

DFWPMA also provides medical services supporting weight management, obesity treatment, diabetes management, thyroid health, and other metabolic conditions. Our providers can help patients assess their eligibility for GLP-1 medications, monitor treatment-related symptoms, and address potential side effects through individualized medical evaluations. 

With locations in Fort Worth, Sherman, and Frisco, Texas, DFWPMA offers access to multiple medical specialties for patients seeking GLP-1 prescription consultations and ongoing healthcare. To schedule an appointment, call (903) 957-0082 or visit DFWPMA’s Medical Weight Management services.